Robert W Postma - 22 Jun 2022 Form 4 Insider Report for Alaunos Therapeutics, Inc. (TCRT)

Role
Director
Signature
/s/ Melinda Lackey, Attorney-in-Fact
Issuer symbol
TCRT
Transactions as of
22 Jun 2022
Net transactions value
$0
Form type
4
Filing time
24 Jun 2022, 16:35:17 UTC
Previous filing
03 Sep 2021
Next filing
01 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TCRT Common Stock Award $0 +40,000 +3.3% $0.000000 1,241,870 22 Jun 2022 Direct F1
holding TCRT Common Stock 4,250,000 22 Jun 2022 See Footnote F2
holding TCRT Common Stock 3,574 22 Jun 2022 By Spouse's IRA

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TCRT Employee Stock Option (right to buy) Award $0 +100,000 $0.000000 100,000 22 Jun 2022 Common Stock 100,000 $0.8200 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 946,970 shares of common stock underlying units of the Issuer (the "Units"). Each Unit is comprised of one share of common stock and one warrant to acquire one share of common stock. The Reporting Person previously purchased 946,970 Units in a private placement transaction with the Issuer.
F2 The shares are directly held by WaterMill Asset Management Corp. ("WaterMill"). The Reporting Person serves as the principal of WaterMill.
F3 The option vests in twelve equal monthly installments beginning on July 13, 2022.

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney